
A 20-week, multi-center, randomized, double-blind placebo controlled, preliminary study to evaluate the safety and efficacy of two fixed doses of a cholinesterase inhibitor in migraine prophylaxis.
A randomized, double blind, placebo controlled trial to evaluate the safety and efficacy of a cholinesterase inhibitor in subjects with mild cognitive impairment (MCI) clinically at risk for development of probable Alzheimer’s disease.
A randomized, double blind, placebo controlled, parallel group trial to assess the efficacy and safety of an anti-epileptic in the prophylaxis of migraine.
A multi-center, randomized, double blind placebo controlled parallel group trial to assess the efficacy of a triptan in the acute treatment of a migraine during the mild intensity phase of an attack in patients highly disabled by migraine.
A double blind, placebo controlled, two attack cross-over study to assess the efficacy of a triptan in the acute treatment for mild migraine headache.
An open-label evaluation of the long-term safety of a 5HT, receptor agonist as short-term prophylactic treatment for menstrually associated migraine.
A randomized, double blind, placebo controlled single, crossover study to compare effects of two medications used to treat overactive bladder and placebo on cognitive function in healthy elderly subjects.
A multi-center, randomized, double-blind, parallel group, single dose, placebo controlled study of the efficacy and safety of a combination medication in subjects with acute migraine attacks.
An OTC plus sinus medication vs. OTC vs. triptan in migraine headache study.
A double blind, placebo-controlled study to evaluate the efficacy of Amantadine in the prevention and treatment of Influenza A.
A four-year study sponsored by the National Institutes of Health on the safety and efficacy of an influenza vaccine in the form on Nose Drops in Children and Adults. Flu 1 / Flu 2
A four-year study sponsored by the National Institutes of Health on the safety and efficacy of a rotavirus vaccine in children and adults. Rota 1